p53-binding protein 1 is fused to the platelet-derived growth factor receptor β in a patient with a t(5;15)(q33;q22) and an imatinib-responsive eosinophilic myeloproliferative disorder

Cancer Research

Volumn 64, Issue 20, 2004, Pages 7216-7219

  Grand, Francis H ^a   Burgstaller, Sonja ^b   Kühr, Thomas ^b   Baxter, E Joanna ^a   Webersinke, Gerald ^c   Thaler, Josef ^b   Chase, Andrew J ^a   Cross, Nicholas C P ^a,d  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b General Hospital of Wels   (Austria)

^c Krankenhaus der Barmherzigen Schwestern Linz   (Austria)

^d SALISBURY DISTRICT HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; DNA; IMATINIB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN P53;

AGED; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DISEASE ASSOCIATION; DNA DAMAGE; EOSINOPHIL; GENE FUSION; GENOMICS; HUMAN; IN SITU HYBRIDIZATION; MALE; MYELOPROLIFERATIVE DISORDER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN;

AGED; AMINO ACID SEQUENCE; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 5; EOSINOPHILIA; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MOLECULAR SEQUENCE DATA; MYELOPROLIFERATIVE DISORDERS; ONCOGENE PROTEINS, FUSION; PHOSPHOPROTEINS; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-SIS; PYRIMIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

EID: 5644271514     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-2005     Document Type: Article

References (17)

1. Cross NCP, Reiter A. Tyrosine kinase fusion genes in chronic myeloproliferative diseases. Leukemia (Baltimore) 2002;16:1207-12.
2. Apperley JF, Gardembas M, Melo JV, et al. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta. New Engl J of Med 2002;347:481-7.
3. Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003;348:1201-14.
4. Pardanani A, Tefferi A. Imatinib targets other than bcr/abl and their clinical relevance in myeloid disorders. Blood Epub 2004 May 27.
5. Steer EJ, Cross NCP. Myeloproliferative Disorders with Translocation of Chromosomes 5q31-35: Role of the Platelet-Derived Growth Factor Receptor Beta. Acta Haematol 2002;107:113-22.
6. Wilkinson K, Velloso ER, Lopes LF, et al. Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: involvement of PDGFRB and response to imatinib. Blood 2003;102:4187-90.
7. Morerio C, Acquila M, Rosanda C, et al. HCMOGT-1 is a novel fusion partner to PDGFRB in juvenile myelomonocytic leukemia with t(5;17)(q33;p11.2). Cancer Res 2004;64:2649-51.
8. Vizmanos JL, Novo FJ, Roman JP, et al. NIN, a gene encoding a CEP110-like centrosomal protein, is fused to PDGFRB in a patient with a t(5;14)(q33;q24) and an imatinib-responsive myeloproliferative disorder. Cancer Res 2004;64:2673-6.
9. Baxter EJ, Kulkarni S, Vizmanos JL, et al. Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL negative chronic myeloproliferative disorders. Br J of Haematol 2003;120:251-6.
10. Iwabuchi K, Bartel PL, Li B, Marraccino R, Fields S. Two cellular proteins that bind to wild-type but not mutant p53. Proc Natl Acad Sci USA 1994;91:6098-102.
11. Iwabuchi K, Li B, Massa HF, Trask BJ, Date T, Fields S. Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2. J Biol Chem 1998;273:26061-8.
12. Derbyshire DJ, Basu BP, Serpell LC, et al. Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor. EMBO J 2002;21:3863-72.
13. Anderson L, Henderson C, Adachi Y. Phosphorylation and rapid relocalization of 53BP1 to nuclear foci upon DNA damage. Mol Cell Biol 2001;21:1719-29.
14. DiTullio RA Jr., Mochan TA, Venere M, et al. 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer. Nat Cell Biol 2002;4:998-1002.
15. Iwabuchi K, Basu BP, Kysela B, et al. Potential role for 53BP1 in DNA end-joining repair through direct interaction with DNA. J Biol Chem 2003;278:36487-95.
16. Ward IM, Minn K, van Deursen J, Chen J. p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice. Mol Cell Biol 2003;23:2556-63.
17. Lupas A, Van Dyke M, Stock J. Predicting coiled coils from protein sequences. Science (Wash DC) 1991;252:1162-64.